Philippe Roche
Papers
1
Total Citations
72
H-Index
1
About
Dr. Philippe Roche is a leading figure in computational and medicinal chemistry, whose work is reshaping the hit-to-lead (H2L) optimization phase of drug discovery. His primary research focuses on developing integrated, automated strategies that bridge the gap between fragment-based screening and lead optimization. Dr. Roche’s most notable contribution is the "Diversity-Oriented-Target-Focused-Synthesis" (DOTFS) approach, a groundbreaking framework that combines fragment growing with automated synthesis to dramatically accelerate the H2L process. This strategy, detailed in his highly cited 2018 paper (72 citations), offers a time- and cost-efficient solution to one of the most persistent bottlenecks in drug development. By automating the optimization of fragment hits into potent leads, his work promises to reduce the manual effort and lengthy timelines traditionally required. Dr. Roche’s impact is evident in the growing adoption of his integrated methodologies, which are helping to streamline the journey from initial hit identification to viable drug candidates. His innovative approach stands as a vital contribution to modern drug discovery, offering a practical pathway to faster, more efficient therapeutic development.
Research Focus
Key Achievements
Top Papers
- 1